Refractory case of ulcerative colitis with idiopathic thrombocytopenic purpura successfully treated by Janus kinase inhibitor tofacitinib: A case report

Figure 1 The administration of tofacitinib subsequently led to the induction of remission. A: The clinical course before and after tofacitinib therapy; B: Endoscopic aspects of the colon before and after tofacitinib treatment. There are spontaneous bleeding and ulcerations before tofacitinib treatment, and they improved after tofacitinib treatment.

Figure 2 Distinct molecular signatures seemed to be regulated by Janus kinase